Resveratrol enhances NK cell cytotoxicity: possible role for aryl hydrocarbon receptor.
Bachleda
Petr
P
Vrzal
Radim
R
Dvorak
Zdenek
Z
D000818:Animals; D000873:Anthracenes / Q000494:pharmacology; D004305:Dose-Response Relationship, Drug; D004791:Enzyme Inhibitors / Q000494:pharmacology*; D005786:Gene Expression Regulation; D056945:Hep G2 Cells; D006801:Humans; D007694:Killer Cells, Natural / Q000187:drug effects* / Q000378:metabolism; D048670:MAP Kinase Kinase 4 / Q000378:metabolism; D000072317:Polychlorinated Dibenzodioxins / Q000031:analogs & derivatives / Q000494:pharmacology; D018336:Receptors, Aryl Hydrocarbon / Q000819:agonists / Q000378:metabolism*; D000077185:Resveratrol; D013267:Stilbenes / Q000494:pharmacology*
D000873:Anthracenes; D004791:Enzyme Inhibitors; D000072317:Polychlorinated Dibenzodioxins; D018336:Receptors, Aryl Hydrocarbon; D013267:Stilbenes; C432165:pyrazolanthrone; C445379:1,2,7,8-tetrachlorodibenzo-p-dioxin; D048670:MAP Kinase Kinase 4; D000077185:Resveratrol